Why is Dr Reddy's Labs falling/rising?

As of 23-Jul, Dr Reddys Laboratories Ltd's stock price is currently at 1,247.55, reflecting an increase of 7.15 (0.58%). The stock has shown mixed performance recently, with a decline of 0.96% over the past week and a more significant drop of 5.32% over the past month. However, today's trading activity indicates a rising investor participation, with a delivery volume increase of 23.18% compared to the 5-day average. The stock is trading above its 100-day and 200-day moving averages but below its 5-day, 20-day, and 50-day moving averages. Despite a negative return of -9.18% over the past year, the company maintains strong fundamentals, including a low debt-to-equity ratio and a healthy return on equity of 16.9, which may contribute to its recent price increase.
Broader market context shows that while Dr Reddys Laboratories has underperformed the market with a -9.18% return over the past year compared to the Sensex's +2.86%, it has still attracted significant institutional interest, with holdings at 62.91%. This suggests that institutional investors, who typically have more resources to analyze company fundamentals, remain confident in the company's long-term prospects despite its recent underperformance. The broader market has seen a slight uptick, with the Sensex gaining 0.11% over the past week, indicating a generally stable market environment that may support the stock's recent upward movement.